nodes	percent_of_prediction	percent_of_DWPC	metapath
Crizotinib—JAK2—anemia	0.535	1	CbGaD
Crizotinib—EPHA5—endocrine gland—anemia	0.000408	0.00207	CbGeAlD
Crizotinib—YES1—hematopoietic system—anemia	0.000407	0.00207	CbGeAlD
Crizotinib—LYN—endocrine gland—anemia	0.000406	0.00206	CbGeAlD
Crizotinib—LIMK2—blood—anemia	0.000404	0.00205	CbGeAlD
Crizotinib—PTK2—cortex of kidney—anemia	0.000404	0.00205	CbGeAlD
Crizotinib—TBK1—cortex of kidney—anemia	0.000404	0.00205	CbGeAlD
Crizotinib—TNK1—endocrine gland—anemia	0.000404	0.00205	CbGeAlD
Crizotinib—STK10—hematopoietic system—anemia	0.000404	0.00205	CbGeAlD
Crizotinib—NUAK2—blood—anemia	0.000403	0.00204	CbGeAlD
Crizotinib—TAOK3—hematopoietic system—anemia	0.000402	0.00204	CbGeAlD
Crizotinib—TYK2—cortex of kidney—anemia	0.000402	0.00204	CbGeAlD
Crizotinib—EPHA4—gonad—anemia	0.000401	0.00203	CbGeAlD
Crizotinib—MAP3K12—blood—anemia	0.0004	0.00203	CbGeAlD
Crizotinib—FLT3—blood—anemia	0.0004	0.00203	CbGeAlD
Crizotinib—ACVR1—blood—anemia	0.0004	0.00203	CbGeAlD
Crizotinib—MERTK—bone marrow—anemia	0.0004	0.00203	CbGeAlD
Crizotinib—BMPR1B—endocrine gland—anemia	0.0004	0.00203	CbGeAlD
Crizotinib—RPS6KB1—kidney—anemia	0.000399	0.00203	CbGeAlD
Crizotinib—IRAK1—cortex of kidney—anemia	0.000396	0.00201	CbGeAlD
Crizotinib—CSF1R—embryo—anemia	0.000394	0.002	CbGeAlD
Crizotinib—MAP3K2—gonad—anemia	0.000393	0.002	CbGeAlD
Crizotinib—IGF1R—endocrine gland—anemia	0.000392	0.00199	CbGeAlD
Crizotinib—TNK2—endocrine gland—anemia	0.000392	0.00199	CbGeAlD
Crizotinib—SRC—hematopoietic system—anemia	0.000392	0.00199	CbGeAlD
Crizotinib—NUAK2—bone marrow—anemia	0.00039	0.00198	CbGeAlD
Crizotinib—STK4—liver—anemia	0.000389	0.00198	CbGeAlD
Crizotinib—RPS6KB1—cortex of kidney—anemia	0.000389	0.00197	CbGeAlD
Crizotinib—PTK2B—lymphoid tissue—anemia	0.000387	0.00196	CbGeAlD
Crizotinib—FLT3—bone marrow—anemia	0.000387	0.00196	CbGeAlD
Crizotinib—ACVR1—bone marrow—anemia	0.000387	0.00196	CbGeAlD
Crizotinib—MAP4K2—endocrine gland—anemia	0.000387	0.00196	CbGeAlD
Crizotinib—TBK1—gonad—anemia	0.000385	0.00195	CbGeAlD
Crizotinib—PTK2—gonad—anemia	0.000385	0.00195	CbGeAlD
Crizotinib—AXL—cortex of kidney—anemia	0.000385	0.00195	CbGeAlD
Crizotinib—PTK2B—digestive system—anemia	0.000382	0.00194	CbGeAlD
Crizotinib—ABL2—blood—anemia	0.000382	0.00194	CbGeAlD
Crizotinib—YES1—nephron tubule—anemia	0.00038	0.00193	CbGeAlD
Crizotinib—RIPK2—digestive system—anemia	0.000379	0.00192	CbGeAlD
Crizotinib—EPHB4—kidney—anemia	0.000378	0.00192	CbGeAlD
Crizotinib—BMP2K—blood—anemia	0.000377	0.00191	CbGeAlD
Crizotinib—JAK2—kidney—anemia	0.000375	0.0019	CbGeAlD
Crizotinib—TAOK3—nephron tubule—anemia	0.000375	0.0019	CbGeAlD
Crizotinib—AURKA—endocrine gland—anemia	0.000372	0.00189	CbGeAlD
Crizotinib—SLK—cortex of kidney—anemia	0.000371	0.00188	CbGeAlD
Crizotinib—TESK1—endocrine gland—anemia	0.000369	0.00187	CbGeAlD
Crizotinib—FER—liver—anemia	0.000368	0.00187	CbGeAlD
Crizotinib—EPHB4—cortex of kidney—anemia	0.000368	0.00187	CbGeAlD
Crizotinib—AXL—gonad—anemia	0.000367	0.00186	CbGeAlD
Crizotinib—LYN—liver—anemia	0.000366	0.00186	CbGeAlD
Crizotinib—JAK2—cortex of kidney—anemia	0.000365	0.00185	CbGeAlD
Crizotinib—BMP2K—bone marrow—anemia	0.000365	0.00185	CbGeAlD
Crizotinib—PTK2B—blood—anemia	0.000364	0.00185	CbGeAlD
Crizotinib—TNK1—liver—anemia	0.000364	0.00185	CbGeAlD
Crizotinib—MAP3K2—lymphoid tissue—anemia	0.000364	0.00185	CbGeAlD
Crizotinib—TEK—kidney—anemia	0.000362	0.00183	CbGeAlD
Crizotinib—RIPK2—blood—anemia	0.000361	0.00183	CbGeAlD
Crizotinib—MERTK—endocrine gland—anemia	0.000359	0.00182	CbGeAlD
Crizotinib—PTK2—lymphoid tissue—anemia	0.000357	0.00181	CbGeAlD
Crizotinib—TBK1—lymphoid tissue—anemia	0.000357	0.00181	CbGeAlD
Crizotinib—TYK2—lymphoid tissue—anemia	0.000354	0.0018	CbGeAlD
Crizotinib—TNK2—liver—anemia	0.000354	0.00179	CbGeAlD
Crizotinib—IGF1R—liver—anemia	0.000354	0.00179	CbGeAlD
Crizotinib—PTK2B—bone marrow—anemia	0.000353	0.00179	CbGeAlD
Crizotinib—TBK1—digestive system—anemia	0.000352	0.00179	CbGeAlD
Crizotinib—PTK2—digestive system—anemia	0.000352	0.00179	CbGeAlD
Crizotinib—TEK—cortex of kidney—anemia	0.000352	0.00179	CbGeAlD
Crizotinib—MAP3K3—cortex of kidney—anemia	0.000352	0.00179	CbGeAlD
Crizotinib—MAP4K5—cortex of kidney—anemia	0.000352	0.00179	CbGeAlD
Crizotinib—CSF1R—hematopoietic system—anemia	0.000352	0.00179	CbGeAlD
Crizotinib—LIMK2—endocrine gland—anemia	0.000351	0.00178	CbGeAlD
Crizotinib—TYK2—digestive system—anemia	0.00035	0.00178	CbGeAlD
Crizotinib—RIPK2—bone marrow—anemia	0.00035	0.00177	CbGeAlD
Crizotinib—EPHA4—blood—anemia	0.000349	0.00177	CbGeAlD
Crizotinib—MAP4K2—liver—anemia	0.000349	0.00177	CbGeAlD
Crizotinib—JAK2—gonad—anemia	0.000348	0.00177	CbGeAlD
Crizotinib—MAP3K12—endocrine gland—anemia	0.000347	0.00176	CbGeAlD
Crizotinib—ACVR1—endocrine gland—anemia	0.000347	0.00176	CbGeAlD
Crizotinib—FLT3—endocrine gland—anemia	0.000347	0.00176	CbGeAlD
Crizotinib—STK3—liver—anemia	0.000344	0.00175	CbGeAlD
Crizotinib—TIE1—liver—anemia	0.000344	0.00175	CbGeAlD
Crizotinib—RPS6KB1—lymphoid tissue—anemia	0.000343	0.00174	CbGeAlD
Crizotinib—MAP3K2—blood—anemia	0.000343	0.00174	CbGeAlD
Crizotinib—FGR—lymphoid tissue—anemia	0.000341	0.00173	CbGeAlD
Crizotinib—STK35—endocrine gland—anemia	0.00034	0.00173	CbGeAlD
Crizotinib—AXL—lymphoid tissue—anemia	0.00034	0.00172	CbGeAlD
Crizotinib—RPS6KB1—digestive system—anemia	0.000339	0.00172	CbGeAlD
Crizotinib—FGR—digestive system—anemia	0.000337	0.00171	CbGeAlD
Crizotinib—EPHB6—cortex of kidney—anemia	0.000337	0.00171	CbGeAlD
Crizotinib—PTK2—blood—anemia	0.000336	0.0017	CbGeAlD
Crizotinib—TBK1—blood—anemia	0.000336	0.0017	CbGeAlD
Crizotinib—MAP4K5—gonad—anemia	0.000335	0.0017	CbGeAlD
Crizotinib—MAP3K3—gonad—anemia	0.000335	0.0017	CbGeAlD
Crizotinib—AURKA—liver—anemia	0.000335	0.0017	CbGeAlD
Crizotinib—YES1—kidney—anemia	0.000334	0.00169	CbGeAlD
Crizotinib—TYK2—blood—anemia	0.000333	0.00169	CbGeAlD
Crizotinib—TESK1—liver—anemia	0.000332	0.00169	CbGeAlD
Crizotinib—MAP3K2—bone marrow—anemia	0.000332	0.00168	CbGeAlD
Crizotinib—STK10—kidney—anemia	0.000331	0.00168	CbGeAlD
Crizotinib—TAOK3—kidney—anemia	0.00033	0.00167	CbGeAlD
Crizotinib—IRAK1—blood—anemia	0.000329	0.00167	CbGeAlD
Crizotinib—BMP2K—endocrine gland—anemia	0.000327	0.00166	CbGeAlD
Crizotinib—YES1—cortex of kidney—anemia	0.000325	0.00165	CbGeAlD
Crizotinib—TBK1—bone marrow—anemia	0.000325	0.00165	CbGeAlD
Crizotinib—MERTK—liver—anemia	0.000323	0.00164	CbGeAlD
Crizotinib—RPS6KB1—blood—anemia	0.000323	0.00164	CbGeAlD
Crizotinib—TYK2—bone marrow—anemia	0.000322	0.00164	CbGeAlD
Crizotinib—JAK2—lymphoid tissue—anemia	0.000322	0.00163	CbGeAlD
Crizotinib—SRC—kidney—anemia	0.000321	0.00163	CbGeAlD
Crizotinib—TAOK3—cortex of kidney—anemia	0.000321	0.00163	CbGeAlD
Crizotinib—LCK—blood—anemia	0.000321	0.00163	CbGeAlD
Crizotinib—FGR—blood—anemia	0.000321	0.00163	CbGeAlD
Crizotinib—EPHB4—digestive system—anemia	0.000321	0.00163	CbGeAlD
Crizotinib—EPHA2—lymphoid tissue—anemia	0.000318	0.00162	CbGeAlD
Crizotinib—IRAK1—bone marrow—anemia	0.000318	0.00162	CbGeAlD
Crizotinib—JAK2—digestive system—anemia	0.000318	0.00162	CbGeAlD
Crizotinib—LIMK2—liver—anemia	0.000316	0.0016	CbGeAlD
Crizotinib—PTK2B—endocrine gland—anemia	0.000316	0.0016	CbGeAlD
Crizotinib—NUAK2—liver—anemia	0.000315	0.0016	CbGeAlD
Crizotinib—EPHA2—digestive system—anemia	0.000314	0.0016	CbGeAlD
Crizotinib—RIPK2—endocrine gland—anemia	0.000313	0.00159	CbGeAlD
Crizotinib—MAP3K12—liver—anemia	0.000313	0.00159	CbGeAlD
Crizotinib—ACVR1—liver—anemia	0.000313	0.00159	CbGeAlD
Crizotinib—FLT3—liver—anemia	0.000313	0.00159	CbGeAlD
Crizotinib—RPS6KB1—bone marrow—anemia	0.000312	0.00158	CbGeAlD
Crizotinib—ABL1—embryo—anemia	0.000312	0.00158	CbGeAlD
Crizotinib—MAP4K5—lymphoid tissue—anemia	0.000311	0.00158	CbGeAlD
Crizotinib—TEK—lymphoid tissue—anemia	0.000311	0.00158	CbGeAlD
Crizotinib—FGR—bone marrow—anemia	0.00031	0.00158	CbGeAlD
Crizotinib—LCK—bone marrow—anemia	0.00031	0.00158	CbGeAlD
Crizotinib—YES1—gonad—anemia	0.00031	0.00157	CbGeAlD
Crizotinib—SLK—blood—anemia	0.000308	0.00156	CbGeAlD
Crizotinib—STK10—gonad—anemia	0.000307	0.00156	CbGeAlD
Crizotinib—STK35—liver—anemia	0.000307	0.00156	CbGeAlD
Crizotinib—EPHB4—blood—anemia	0.000305	0.00155	CbGeAlD
Crizotinib—JAK2—blood—anemia	0.000303	0.00154	CbGeAlD
Crizotinib—EPHA4—endocrine gland—anemia	0.000303	0.00154	CbGeAlD
Crizotinib—EPHA2—blood—anemia	0.0003	0.00152	CbGeAlD
Crizotinib—ABL2—liver—anemia	0.000299	0.00152	CbGeAlD
Crizotinib—SRC—gonad—anemia	0.000298	0.00151	CbGeAlD
Crizotinib—SLK—bone marrow—anemia	0.000298	0.00151	CbGeAlD
Crizotinib—MAP3K2—endocrine gland—anemia	0.000297	0.00151	CbGeAlD
Crizotinib—EPHB4—bone marrow—anemia	0.000295	0.0015	CbGeAlD
Crizotinib—BMP2K—liver—anemia	0.000295	0.0015	CbGeAlD
Crizotinib—CYP3A5—blood plasma—anemia	0.000294	0.00149	CbGeAlD
Crizotinib—JAK2—bone marrow—anemia	0.000293	0.00149	CbGeAlD
Crizotinib—MAP3K3—blood—anemia	0.000292	0.00148	CbGeAlD
Crizotinib—MAP4K5—blood—anemia	0.000292	0.00148	CbGeAlD
Crizotinib—TEK—blood—anemia	0.000292	0.00148	CbGeAlD
Crizotinib—TBK1—endocrine gland—anemia	0.000291	0.00148	CbGeAlD
Crizotinib—PTK2—endocrine gland—anemia	0.000291	0.00148	CbGeAlD
Crizotinib—TYK2—endocrine gland—anemia	0.000289	0.00147	CbGeAlD
Crizotinib—YES1—lymphoid tissue—anemia	0.000287	0.00146	CbGeAlD
Crizotinib—PTK2B—liver—anemia	0.000285	0.00145	CbGeAlD
Crizotinib—STK10—lymphoid tissue—anemia	0.000284	0.00144	CbGeAlD
Crizotinib—YES1—digestive system—anemia	0.000283	0.00144	CbGeAlD
Crizotinib—TAOK3—lymphoid tissue—anemia	0.000283	0.00144	CbGeAlD
Crizotinib—MAP4K5—bone marrow—anemia	0.000283	0.00143	CbGeAlD
Crizotinib—MAP3K3—bone marrow—anemia	0.000283	0.00143	CbGeAlD
Crizotinib—RIPK2—liver—anemia	0.000283	0.00143	CbGeAlD
Crizotinib—STK10—digestive system—anemia	0.000281	0.00142	CbGeAlD
Crizotinib—RPS6KB1—endocrine gland—anemia	0.00028	0.00142	CbGeAlD
Crizotinib—TAOK3—digestive system—anemia	0.00028	0.00142	CbGeAlD
Crizotinib—EPHB6—blood—anemia	0.000279	0.00142	CbGeAlD
Crizotinib—FGR—endocrine gland—anemia	0.000278	0.00141	CbGeAlD
Crizotinib—ABL1—hematopoietic system—anemia	0.000278	0.00141	CbGeAlD
Crizotinib—AXL—endocrine gland—anemia	0.000277	0.00141	CbGeAlD
Crizotinib—SRC—lymphoid tissue—anemia	0.000276	0.0014	CbGeAlD
Crizotinib—SRC—digestive system—anemia	0.000273	0.00138	CbGeAlD
Crizotinib—YES1—blood—anemia	0.00027	0.00137	CbGeAlD
Crizotinib—MAP3K2—liver—anemia	0.000268	0.00136	CbGeAlD
Crizotinib—CSF1R—gonad—anemia	0.000268	0.00136	CbGeAlD
Crizotinib—STK10—blood—anemia	0.000267	0.00136	CbGeAlD
Crizotinib—TAOK3—blood—anemia	0.000266	0.00135	CbGeAlD
Crizotinib—EPHB4—endocrine gland—anemia	0.000265	0.00134	CbGeAlD
Crizotinib—JAK2—endocrine gland—anemia	0.000263	0.00133	CbGeAlD
Crizotinib—TBK1—liver—anemia	0.000262	0.00133	CbGeAlD
Crizotinib—PTK2—liver—anemia	0.000262	0.00133	CbGeAlD
Crizotinib—YES1—bone marrow—anemia	0.000261	0.00133	CbGeAlD
Crizotinib—TYK2—liver—anemia	0.000261	0.00132	CbGeAlD
Crizotinib—EPHA2—endocrine gland—anemia	0.00026	0.00132	CbGeAlD
Crizotinib—SRC—blood—anemia	0.00026	0.00132	CbGeAlD
Crizotinib—ABL1—nephron tubule—anemia	0.000259	0.00132	CbGeAlD
Crizotinib—STK10—bone marrow—anemia	0.000259	0.00131	CbGeAlD
Crizotinib—TAOK3—bone marrow—anemia	0.000258	0.00131	CbGeAlD
Crizotinib—IRAK1—liver—anemia	0.000257	0.00131	CbGeAlD
Crizotinib—MAP4K5—endocrine gland—anemia	0.000253	0.00129	CbGeAlD
Crizotinib—TEK—endocrine gland—anemia	0.000253	0.00129	CbGeAlD
Crizotinib—MAP3K3—endocrine gland—anemia	0.000253	0.00129	CbGeAlD
Crizotinib—RPS6KB1—liver—anemia	0.000252	0.00128	CbGeAlD
Crizotinib—FGR—liver—anemia	0.000251	0.00127	CbGeAlD
Crizotinib—LCK—liver—anemia	0.000251	0.00127	CbGeAlD
Crizotinib—AXL—liver—anemia	0.00025	0.00127	CbGeAlD
Crizotinib—CSF1R—lymphoid tissue—anemia	0.000248	0.00126	CbGeAlD
Crizotinib—CSF1R—digestive system—anemia	0.000245	0.00124	CbGeAlD
Crizotinib—SLK—liver—anemia	0.000241	0.00122	CbGeAlD
Crizotinib—EPHB4—liver—anemia	0.000239	0.00121	CbGeAlD
Crizotinib—JAK2—liver—anemia	0.000237	0.0012	CbGeAlD
Crizotinib—EPHA2—liver—anemia	0.000234	0.00119	CbGeAlD
Crizotinib—YES1—endocrine gland—anemia	0.000234	0.00119	CbGeAlD
Crizotinib—CSF1R—blood—anemia	0.000233	0.00118	CbGeAlD
Crizotinib—STK10—endocrine gland—anemia	0.000232	0.00118	CbGeAlD
Crizotinib—TAOK3—endocrine gland—anemia	0.000231	0.00117	CbGeAlD
Crizotinib—MAP3K3—liver—anemia	0.000229	0.00116	CbGeAlD
Crizotinib—MAP4K5—liver—anemia	0.000229	0.00116	CbGeAlD
Crizotinib—TEK—liver—anemia	0.000229	0.00116	CbGeAlD
Crizotinib—ABL1—kidney—anemia	0.000228	0.00116	CbGeAlD
Crizotinib—CSF1R—bone marrow—anemia	0.000226	0.00114	CbGeAlD
Crizotinib—SRC—endocrine gland—anemia	0.000225	0.00114	CbGeAlD
Crizotinib—ABL1—cortex of kidney—anemia	0.000222	0.00113	CbGeAlD
Crizotinib—CYP3A4—blood plasma—anemia	0.000221	0.00112	CbGeAlD
Crizotinib—ABL1—gonad—anemia	0.000211	0.00107	CbGeAlD
Crizotinib—YES1—liver—anemia	0.000211	0.00107	CbGeAlD
Crizotinib—STK10—liver—anemia	0.000209	0.00106	CbGeAlD
Crizotinib—TAOK3—liver—anemia	0.000208	0.00106	CbGeAlD
Crizotinib—SRC—liver—anemia	0.000203	0.00103	CbGeAlD
Crizotinib—CSF1R—endocrine gland—anemia	0.000202	0.00103	CbGeAlD
Crizotinib—ABL1—lymphoid tissue—anemia	0.000196	0.000994	CbGeAlD
Crizotinib—ABL1—digestive system—anemia	0.000193	0.000981	CbGeAlD
Crizotinib—ABL1—blood—anemia	0.000184	0.000935	CbGeAlD
Crizotinib—CSF1R—liver—anemia	0.000182	0.000925	CbGeAlD
Crizotinib—ABL1—bone marrow—anemia	0.000178	0.000905	CbGeAlD
Crizotinib—CYP3A5—hematopoietic system—anemia	0.000163	0.000826	CbGeAlD
Crizotinib—ABL1—endocrine gland—anemia	0.00016	0.000811	CbGeAlD
Crizotinib—ABCB1—blood plasma—anemia	0.000156	0.000794	CbGeAlD
Crizotinib—CYP3A5—nephron tubule—anemia	0.000152	0.000771	CbGeAlD
Crizotinib—ABL1—liver—anemia	0.000144	0.000731	CbGeAlD
Crizotinib—CYP3A5—kidney—anemia	0.000133	0.000677	CbGeAlD
Crizotinib—CYP3A5—cortex of kidney—anemia	0.00013	0.000659	CbGeAlD
Crizotinib—CYP3A4—hematopoietic system—anemia	0.000122	0.00062	CbGeAlD
Crizotinib—CYP3A5—digestive system—anemia	0.000113	0.000574	CbGeAlD
Crizotinib—CYP3A5—blood—anemia	0.000108	0.000547	CbGeAlD
Crizotinib—CYP3A4—kidney—anemia	0.0001	0.000508	CbGeAlD
Crizotinib—ABCB1—embryo—anemia	9.69e-05	0.000492	CbGeAlD
Crizotinib—CYP3A5—endocrine gland—anemia	9.35e-05	0.000475	CbGeAlD
Crizotinib—ABCB1—hematopoietic system—anemia	8.65e-05	0.000439	CbGeAlD
Crizotinib—CYP3A4—digestive system—anemia	8.5e-05	0.000431	CbGeAlD
Crizotinib—CYP3A5—liver—anemia	8.43e-05	0.000428	CbGeAlD
Crizotinib—CYP3A4—blood—anemia	8.09e-05	0.000411	CbGeAlD
Crizotinib—ABCB1—nephron tubule—anemia	8.07e-05	0.000409	CbGeAlD
Crizotinib—ABCB1—kidney—anemia	7.09e-05	0.00036	CbGeAlD
Crizotinib—CYP3A4—endocrine gland—anemia	7.02e-05	0.000356	CbGeAlD
Crizotinib—ABCB1—cortex of kidney—anemia	6.9e-05	0.00035	CbGeAlD
Crizotinib—ABCB1—gonad—anemia	6.58e-05	0.000334	CbGeAlD
Crizotinib—CYP3A4—liver—anemia	6.33e-05	0.000321	CbGeAlD
Crizotinib—ABCB1—lymphoid tissue—anemia	6.09e-05	0.000309	CbGeAlD
Crizotinib—ABCB1—digestive system—anemia	6.01e-05	0.000305	CbGeAlD
Crizotinib—ABCB1—blood—anemia	5.73e-05	0.000291	CbGeAlD
Crizotinib—ABCB1—bone marrow—anemia	5.54e-05	0.000281	CbGeAlD
Crizotinib—ABCB1—endocrine gland—anemia	4.97e-05	0.000252	CbGeAlD
Crizotinib—ABCB1—liver—anemia	4.48e-05	0.000227	CbGeAlD
Crizotinib—PTK2—Signaling Pathways—F2—anemia	3.02e-06	1.13e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CBL—anemia	3.01e-06	1.12e-05	CbGpPWpGaD
Crizotinib—SRC—Adaptive Immune System—CD4—anemia	3e-06	1.12e-05	CbGpPWpGaD
Crizotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—anemia	3e-06	1.12e-05	CbGpPWpGaD
Crizotinib—BMPR1B—Signaling Pathways—IL6—anemia	2.99e-06	1.11e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL3—anemia	2.98e-06	1.11e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—F2—anemia	2.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—TPI1—anemia	2.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—JAK2—anemia	2.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling by NGF—IL6—anemia	2.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—IRAK1—Innate Immune System—IL6—anemia	2.97e-06	1.11e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—AGT—anemia	2.96e-06	1.11e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—MTHFR—anemia	2.96e-06	1.1e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL1B—anemia	2.95e-06	1.1e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—TERT—anemia	2.95e-06	1.1e-05	CbGpPWpGaD
Crizotinib—LCK—Disease—HLA-A—anemia	2.95e-06	1.1e-05	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL2—anemia	2.94e-06	1.1e-05	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—JAK2—anemia	2.92e-06	1.09e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—DHFR—anemia	2.92e-06	1.09e-05	CbGpPWpGaD
Crizotinib—TBK1—Immune System—IL6—anemia	2.92e-06	1.09e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—HLA-DRB1—anemia	2.92e-06	1.09e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KITLG—anemia	2.91e-06	1.09e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL2—anemia	2.9e-06	1.08e-05	CbGpPWpGaD
Crizotinib—JAK3—Signaling by GPCR—IL6—anemia	2.89e-06	1.08e-05	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—KIT—anemia	2.89e-06	1.08e-05	CbGpPWpGaD
Crizotinib—SRC—Disease—PDGFRB—anemia	2.88e-06	1.08e-05	CbGpPWpGaD
Crizotinib—TYK2—Innate Immune System—IL6—anemia	2.88e-06	1.07e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL1B—anemia	2.86e-06	1.07e-05	CbGpPWpGaD
Crizotinib—TYK2—Disease—CD4—anemia	2.86e-06	1.07e-05	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL2—anemia	2.85e-06	1.06e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MAOB—anemia	2.85e-06	1.06e-05	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—KIT—anemia	2.85e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SLC4A1—anemia	2.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NDUFA2—anemia	2.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HBA2—anemia	2.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PARP1—anemia	2.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—JAK2—Disease—KIT—anemia	2.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—C3—anemia	2.84e-06	1.06e-05	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IGF2—anemia	2.83e-06	1.06e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-A—anemia	2.83e-06	1.06e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—CSF2—anemia	2.83e-06	1.06e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—F2—anemia	2.82e-06	1.05e-05	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—JAK2—anemia	2.8e-06	1.04e-05	CbGpPWpGaD
Crizotinib—MAP3K3—Immune System—IL6—anemia	2.8e-06	1.04e-05	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PRL—anemia	2.8e-06	1.04e-05	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—UGT1A1—anemia	2.79e-06	1.04e-05	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—PDGFRB—anemia	2.78e-06	1.04e-05	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—F2—anemia	2.74e-06	1.02e-05	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT2—anemia	2.73e-06	1.02e-05	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—JAK2—anemia	2.71e-06	1.01e-05	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—KIT—anemia	2.7e-06	1.01e-05	CbGpPWpGaD
Crizotinib—SRC—Immune System—CRP—anemia	2.7e-06	1.01e-05	CbGpPWpGaD
Crizotinib—LCK—Immune System—KIT—anemia	2.69e-06	1e-05	CbGpPWpGaD
Crizotinib—SRC—Axon guidance—IL6—anemia	2.68e-06	1e-05	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CBL—anemia	2.67e-06	9.96e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—JAK2—anemia	2.65e-06	9.89e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—A2M—anemia	2.65e-06	9.89e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—CSF2—anemia	2.65e-06	9.87e-06	CbGpPWpGaD
Crizotinib—JAK3—Immune System—IL6—anemia	2.64e-06	9.86e-06	CbGpPWpGaD
Crizotinib—LYN—Developmental Biology—IL6—anemia	2.64e-06	9.85e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL3—anemia	2.64e-06	9.85e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—JAK2—anemia	2.64e-06	9.84e-06	CbGpPWpGaD
Crizotinib—ABL1—Developmental Biology—IL6—anemia	2.63e-06	9.81e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—KIT—anemia	2.62e-06	9.78e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—MTHFR—anemia	2.62e-06	9.77e-06	CbGpPWpGaD
Crizotinib—FES—Signaling Pathways—IL6—anemia	2.61e-06	9.75e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—TERT—anemia	2.61e-06	9.74e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—HLA-A—anemia	2.61e-06	9.74e-06	CbGpPWpGaD
Crizotinib—JAK2—GPCR downstream signaling—IL2—anemia	2.61e-06	9.73e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—PDGFRB—anemia	2.6e-06	9.71e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IFNG—anemia	2.6e-06	9.7e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SEC24B—anemia	2.6e-06	9.7e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL2—anemia	2.59e-06	9.66e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IFNG—anemia	2.59e-06	9.66e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—HLA-DRB1—anemia	2.58e-06	9.64e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALDOA—anemia	2.57e-06	9.58e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL2—anemia	2.55e-06	9.52e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KITLG—anemia	2.55e-06	9.52e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—CYP1A2—anemia	2.54e-06	9.47e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—NQO1—anemia	2.54e-06	9.47e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GPI—anemia	2.53e-06	9.45e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—C3—anemia	2.53e-06	9.43e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—TERT—anemia	2.52e-06	9.4e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—CD4—anemia	2.51e-06	9.37e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—CD4—anemia	2.5e-06	9.33e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—KIT—anemia	2.48e-06	9.27e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IGF2—anemia	2.48e-06	9.26e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PRL—anemia	2.48e-06	9.24e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—LPIN2—anemia	2.47e-06	9.23e-06	CbGpPWpGaD
Crizotinib—JAK2—Developmental Biology—IL6—anemia	2.47e-06	9.22e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL2—anemia	2.44e-06	9.11e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IFNG—anemia	2.43e-06	9.08e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HBB—anemia	2.42e-06	9.02e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ACSL4—anemia	2.42e-06	9.02e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—AGT—anemia	2.4e-06	8.96e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—KIT—anemia	2.38e-06	8.89e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—TNF—anemia	2.37e-06	8.86e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL2—anemia	2.37e-06	8.84e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL2—anemia	2.37e-06	8.83e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—C3—anemia	2.36e-06	8.83e-06	CbGpPWpGaD
Crizotinib—IGF1R—Signaling Pathways—IL6—anemia	2.36e-06	8.81e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HBA1—anemia	2.36e-06	8.81e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—TERT—anemia	2.36e-06	8.8e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GOT1—anemia	2.36e-06	8.8e-06	CbGpPWpGaD
Crizotinib—RIPK2—Immune System—IL6—anemia	2.35e-06	8.78e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—CD4—anemia	2.35e-06	8.77e-06	CbGpPWpGaD
Crizotinib—LYN—Innate Immune System—IL6—anemia	2.33e-06	8.7e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—JAK2—anemia	2.33e-06	8.69e-06	CbGpPWpGaD
Crizotinib—ABL1—Innate Immune System—IL6—anemia	2.32e-06	8.66e-06	CbGpPWpGaD
Crizotinib—PTK2B—Immune System—IL6—anemia	2.32e-06	8.66e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL1B—anemia	2.32e-06	8.66e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—CSF2—anemia	2.32e-06	8.65e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PGK1—anemia	2.32e-06	8.65e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—UMPS—anemia	2.32e-06	8.65e-06	CbGpPWpGaD
Crizotinib—MAPK7—Signaling Pathways—IL6—anemia	2.31e-06	8.63e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL2—anemia	2.31e-06	8.62e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL1B—anemia	2.31e-06	8.62e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTT1—anemia	2.3e-06	8.6e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL2—anemia	2.3e-06	8.58e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—JAK2—anemia	2.3e-06	8.57e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—PDGFRB—anemia	2.28e-06	8.51e-06	CbGpPWpGaD
Crizotinib—CDK7—Disease—IL6—anemia	2.28e-06	8.5e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GCLC—anemia	2.28e-06	8.5e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—BRIP1—anemia	2.27e-06	8.48e-06	CbGpPWpGaD
Crizotinib—BLK—Immune System—IL6—anemia	2.26e-06	8.45e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KITLG—anemia	2.26e-06	8.43e-06	CbGpPWpGaD
Crizotinib—FGR—Immune System—IL6—anemia	2.26e-06	8.42e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—AGT—anemia	2.25e-06	8.39e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CUBN—anemia	2.23e-06	8.32e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSR—anemia	2.23e-06	8.32e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—F2—anemia	2.22e-06	8.28e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—DHFR—anemia	2.2e-06	8.23e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—KIT—anemia	2.2e-06	8.21e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IGF2—anemia	2.2e-06	8.2e-06	CbGpPWpGaD
Crizotinib—JAK2—Innate Immune System—IL6—anemia	2.18e-06	8.14e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—JAK2—anemia	2.18e-06	8.13e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—JAK2—anemia	2.17e-06	8.1e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL1B—anemia	2.17e-06	8.1e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—CD4—anemia	2.17e-06	8.1e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL2—anemia	2.16e-06	8.07e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TCN2—anemia	2.15e-06	8.04e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—PKLR—anemia	2.15e-06	8.04e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IFNG—anemia	2.13e-06	7.95e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—KIT—anemia	2.12e-06	7.92e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—JAK2—anemia	2.11e-06	7.89e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—HMOX1—anemia	2.09e-06	7.79e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALAS1—anemia	2.09e-06	7.78e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—F2—anemia	2.08e-06	7.75e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—C3—anemia	2.07e-06	7.73e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—TERT—anemia	2.06e-06	7.71e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT2—anemia	2.06e-06	7.69e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—CD4—anemia	2.06e-06	7.68e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ADA—anemia	2.05e-06	7.67e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—CSF2—anemia	2.05e-06	7.66e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL2—anemia	2.03e-06	7.58e-06	CbGpPWpGaD
Crizotinib—ABCB1—Transmembrane transport of small molecules—ALB—anemia	2.02e-06	7.54e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—PDGFRB—anemia	2.02e-06	7.53e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—JAK2—anemia	2e-06	7.48e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL2—anemia	2e-06	7.48e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—KIT—anemia	1.99e-06	7.41e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—SEC23A—anemia	1.97e-06	7.35e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—AGT—anemia	1.97e-06	7.34e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—GSTM1—anemia	1.94e-06	7.26e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—JAK2—anemia	1.92e-06	7.17e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—G6PD—anemia	1.92e-06	7.16e-06	CbGpPWpGaD
Crizotinib—SRC—Developmental Biology—IL6—anemia	1.92e-06	7.15e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—NQO1—anemia	1.91e-06	7.15e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—CYP1A2—anemia	1.91e-06	7.15e-06	CbGpPWpGaD
Crizotinib—LCK—Innate Immune System—IL6—anemia	1.91e-06	7.13e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL1B—anemia	1.9e-06	7.1e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—CD4—anemia	1.9e-06	7.09e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL2—anemia	1.9e-06	7.09e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL2—anemia	1.89e-06	7.07e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IFNG—anemia	1.89e-06	7.04e-06	CbGpPWpGaD
Crizotinib—PTK2—Immune System—IL6—anemia	1.85e-06	6.89e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL2—anemia	1.84e-06	6.89e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling by GPCR—IL6—anemia	1.84e-06	6.85e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—C3—anemia	1.83e-06	6.84e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—TPI1—anemia	1.83e-06	6.83e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—TERT—anemia	1.83e-06	6.82e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—CD4—anemia	1.82e-06	6.8e-06	CbGpPWpGaD
Crizotinib—YES1—Immune System—IL6—anemia	1.82e-06	6.8e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—F2—anemia	1.82e-06	6.79e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GOT1—anemia	1.78e-06	6.64e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—JAK2—anemia	1.77e-06	6.62e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MAOB—anemia	1.76e-06	6.55e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—AGT—anemia	1.74e-06	6.5e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—KIT—anemia	1.74e-06	6.49e-06	CbGpPWpGaD
Crizotinib—IRAK1—Immune System—IL6—anemia	1.73e-06	6.45e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—UGT1A1—anemia	1.72e-06	6.43e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—MTHFR—anemia	1.72e-06	6.42e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—JAK2—anemia	1.71e-06	6.39e-06	CbGpPWpGaD
Crizotinib—JAK3—Signaling Pathways—IL6—anemia	1.71e-06	6.37e-06	CbGpPWpGaD
Crizotinib—SRC—Innate Immune System—IL6—anemia	1.69e-06	6.32e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL1B—anemia	1.68e-06	6.28e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—CD4—anemia	1.68e-06	6.28e-06	CbGpPWpGaD
Crizotinib—TYK2—Immune System—IL6—anemia	1.68e-06	6.26e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL2—anemia	1.68e-06	6.26e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—AGT—anemia	1.63e-06	6.1e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—A2M—anemia	1.63e-06	6.09e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—F2—anemia	1.61e-06	6.01e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALDOA—anemia	1.58e-06	5.9e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—HMOX1—anemia	1.58e-06	5.88e-06	CbGpPWpGaD
Crizotinib—TYK2—Disease—IL6—anemia	1.55e-06	5.78e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—KIT—anemia	1.54e-06	5.75e-06	CbGpPWpGaD
Crizotinib—RIPK2—Signaling Pathways—IL6—anemia	1.52e-06	5.68e-06	CbGpPWpGaD
Crizotinib—PTK2B—Signaling Pathways—IL6—anemia	1.5e-06	5.6e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL2—anemia	1.49e-06	5.58e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—GSTM1—anemia	1.47e-06	5.48e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HBA1—anemia	1.45e-06	5.43e-06	CbGpPWpGaD
Crizotinib—NTRK1—Signaling Pathways—IL6—anemia	1.44e-06	5.36e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTT1—anemia	1.42e-06	5.3e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—JAK2—anemia	1.4e-06	5.24e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GCLC—anemia	1.4e-06	5.24e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL2—anemia	1.4e-06	5.22e-06	CbGpPWpGaD
Crizotinib—RPS6KB1—Signaling Pathways—IL6—anemia	1.39e-06	5.19e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling by GPCR—IL6—anemia	1.39e-06	5.19e-06	CbGpPWpGaD
Crizotinib—LYN—Immune System—IL6—anemia	1.36e-06	5.07e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—DHFR—anemia	1.36e-06	5.07e-06	CbGpPWpGaD
Crizotinib—ABL1—Immune System—IL6—anemia	1.35e-06	5.05e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—MTHFR—anemia	1.3e-06	4.84e-06	CbGpPWpGaD
Crizotinib—JAK2—Immune System—IL6—anemia	1.27e-06	4.74e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT2—anemia	1.27e-06	4.74e-06	CbGpPWpGaD
Crizotinib—CYP3A5—Metabolism—ALB—anemia	1.25e-06	4.68e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—JAK2—anemia	1.24e-06	4.64e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—AGT—anemia	1.23e-06	4.6e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL2—anemia	1.22e-06	4.57e-06	CbGpPWpGaD
Crizotinib—PTK2—Signaling Pathways—IL6—anemia	1.19e-06	4.46e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—CYP1A2—anemia	1.18e-06	4.4e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—NQO1—anemia	1.18e-06	4.4e-06	CbGpPWpGaD
Crizotinib—YES1—Signaling Pathways—IL6—anemia	1.18e-06	4.4e-06	CbGpPWpGaD
Crizotinib—JAK2—Disease—IL6—anemia	1.17e-06	4.38e-06	CbGpPWpGaD
Crizotinib—IRAK1—Signaling Pathways—IL6—anemia	1.12e-06	4.17e-06	CbGpPWpGaD
Crizotinib—LCK—Immune System—IL6—anemia	1.11e-06	4.15e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GOT1—anemia	1.1e-06	4.09e-06	CbGpPWpGaD
Crizotinib—TYK2—Signaling Pathways—IL6—anemia	1.08e-06	4.05e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL2—anemia	1.08e-06	4.05e-06	CbGpPWpGaD
Crizotinib—LCK—Disease—IL6—anemia	1.03e-06	3.84e-06	CbGpPWpGaD
Crizotinib—SRC—Immune System—IL6—anemia	9.85e-07	3.68e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—HMOX1—anemia	9.7e-07	3.62e-06	CbGpPWpGaD
Crizotinib—ABCB1—Metabolism—ALB—anemia	9.46e-07	3.53e-06	CbGpPWpGaD
Crizotinib—SRC—Disease—IL6—anemia	9.1e-07	3.4e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—GSTM1—anemia	9.04e-07	3.38e-06	CbGpPWpGaD
Crizotinib—LYN—Signaling Pathways—IL6—anemia	8.78e-07	3.28e-06	CbGpPWpGaD
Crizotinib—JAK2—Signaling Pathways—IL6—anemia	8.22e-07	3.07e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—MTHFR—anemia	7.99e-07	2.98e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—AGT—anemia	7.59e-07	2.83e-06	CbGpPWpGaD
Crizotinib—LCK—Signaling Pathways—IL6—anemia	7.2e-07	2.69e-06	CbGpPWpGaD
Crizotinib—SRC—Signaling Pathways—IL6—anemia	6.37e-07	2.38e-06	CbGpPWpGaD
Crizotinib—CYP3A4—Metabolism—ALB—anemia	5.83e-07	2.18e-06	CbGpPWpGaD
